23andMe has appointed three new independent directors to its board following the mass resignation of all seven of its previous members last month. The biotech company said in an SEC filing that ...
23andMe said it appointed three new independent directors to its board on Monday. All seven of 23andMe's previous directors ...
23andMe said it appointed three new independent directors to its board on Monday. All seven of 23andMe's previous directors resigned in September over its "strategic direction." 23andMe is ...
SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the "Company” or "23andMe”), a leading human genetics and preventive health company, today announced the ...
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report financial ...
Three years ago, the DNA-testing firm 23andMe was a massive success, with a share price higher than Apple's. But, from those ...
When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...
October 31, 2024 00:00 AM UTC - Updated October 31, 2024 19:40 PM UTC 23andMe appoints three former CFOs as new directors—after the previous board all resigned ...
23andMe (ME) announced that the company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the majority independent board and various ...